Document is current
Any future updates will be listed below
-
Authors
Moens, Thomas G. https://orcid.org/0000-0002-4783-6257
Biasetti, Luca https://orcid.org/0000-0003-3274-0559
Scheveneels, Wendy
Smith, Bradley N. https://orcid.org/0000-0002-6980-2453
Troakes, Claire https://orcid.org/0000-0002-1790-7376
Van Damme, Philip https://orcid.org/0000-0002-4010-2357
Vance, Caroline https://orcid.org/0000-0001-5780-6951
Van Den Bosch, Ludo https://orcid.org/0000-0003-0104-4067
- License Information
-
More Information
Article History
Received: 23 May 2025
Revised: 8 January 2026
Accepted: 26 February 2026
First Online: 14 March 2026
Competing interests
: LVDB is the head of the Scientific Advisory Board of Augustine Therapeutics (Leuven, Belgium) and is part of the Investment Advisory Board of Droia Ventures (Meise, Belgium).
: All experiments were performed in accordance with the applicable local guidelines and regulations. Human tissue studies were carried out under the ethical approval of the tissue bank (NHS Research Ethics Committee reference 23/WA/0124). Informed consent was obtained from all subjects for autopsy, neuropathological assessment and research.
